Preoperative cisplatin, fluorouracil, and docetaxel with or without radiotherapy after poor early response to cisplatin and fluorouracil for resectable oesophageal adenocarcinoma (AGITG DOCTOR): results from a multicentre, randomised controlled phase II trial
- A. P. Barbour
- , E. T. Walpole
- , G. T. Mai
- , E. H. Barnes
- , D. I. Watson
- , S. P. Ackland
- , J. M. Martin
- , M. Burge
- , R. Finch
- , C. S. Karapetis
- , J. Shannon
- , L. M. Nott
- , S. Varma
- , G. Marx
- , G. L. Falk
- , V. Gebski
- , M. Oostendorp
- , K. Wilson
- , J. Thomas
- , G. Lampe
Research output: Contribution to journal › Article › peer-review
48
Citations
(Scopus)